Study S000698

Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02084251
Study type: INTERVENTIONAL
Phase: PHASE1
Masking: DOUBLE
Status: COMPLETED
Enrollment: 70
Start: 2014-02
Primary completion: 2014-11
Lead sponsor: PegBio Co., Ltd.
Conditions: Type II Diabetes
Interventions: DRUG:PB-119
Results posted: FALSE

Registered primary outcomes

Safety/Adverse Event Outcome Measure [Up to 3 weeks]

Linked records (1)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0023356	Safety, Tolerability and Pharmacokinetics of Single Dose Polyethylene Glycolated Exenatide Injection (PB-119) in Healthy Volunteers. Cui H, European journal of drug metabolism and pharmacokinetics	2020	Randomized trial	PMID 32006325 DOI	cites ClinicalTrials.gov:NCT02084251; registry reference DERIVED:32006325